The estimated Net Worth of James M Thorburn is at least $9.98 Million dollars as of 23 May 2023. Mr. Thorburn owns over 13,324 units of Twist Bioscience Corp stock worth over $2,752,183 and over the last 9 years he sold TWST stock worth over $4,178,264. In addition, he makes $3,052,200 as Chief Financial Officer at Twist Bioscience Corp.
James has made over 22 trades of the Twist Bioscience Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 13,324 units of TWST stock worth $154,425 on 23 May 2023.
The largest trade he's ever made was exercising 100,000 units of Twist Bioscience Corp stock on 4 September 2020 worth over $1,319,000. On average, James trades about 4,094 units every 37 days since 2015. As of 23 May 2023 he still owns at least 62,042 units of Twist Bioscience Corp stock.
You can see the complete history of Mr. Thorburn stock trades at the bottom of the page.
James M. Thorburn serves as Chief Financial Officer of the Company. Prior to joining us, Mr. Thorburn served as a member of the board of directors of IXYS Corporation, a publicly traded semiconductor company from March 2007 to January 2018. Mr. Thorburn was also Chief Sales Officer and Co-Head of International at Televerde, a demand generation and sales acceleration enterprise, from August 2014 to February 2018. Prior to Televerde, he served as interim CFO of several public and private companies including Enercore, Next Autoworks, Fisker Automotive and Numonyx. Mr. Thorburn served as Chief Executive Officer of Zilog from March 2001 until August 2006. Prior to serving as Chief Executive Officer of Zilog, Mr. Thorburn held various executive positions including Chief Operating Officer of ON Semiconductor, operating consultant with Texas Pacific Group, Chief Financial Officer at Zilog and various management positions at National Semiconductor Corporation. Mr. Thorburn holds a B.Sc. (Hons.) degree from University of Glasgow and passed the Chartered Institute of Management Accountant exams in the United Kingdom.
As the Chief Financial Officer of Twist Bioscience Corp, the total compensation of James Thorburn at Twist Bioscience Corp is $3,052,200. There are 1 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
James Thorburn is 64, he's been the Chief Financial Officer of Twist Bioscience Corp since 2018. There are 3 older and 20 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
James's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell, and Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: